GTBPVSVNCE• 3 Months (Normalized)
GTBP vs VNCE (GT Biopharma Inc. vs Vince Holding Corp.)
Showing Closing Date Range from Jun 27 to Sep 25, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
GTBP Performance $7.1
+%
GT Biopharma Inc.
Normalized Baseline0.00%
VNCE Performance $11.54
+48.07%
Vince Holding Corp.
Normalized Baseline0.00%
Alpha Spread Margin VNCE LEADS
-48.07 pts
VNCE outperforming by 48.07 percentage points
GTBPVNCE
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
GTBP VNCE
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(63 dates)
| Date | GTBP Price | GTBP Gain (%) | VNCE Price | VNCE Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 25, 2026 | $- | $11.54 | +48.07% | - | |
| Sep 24, 2026 | $- | $11.14 | +43.00% | - | |
| Sep 23, 2026 | $7.10 | +1513.64% | $11.11 | +42.62% | +1471.02% |
| Sep 22, 2026 | $- | $10.14 | +30.17% | - | |
| Sep 21, 2026 | $7.18 | +1531.82% | $9.13 | +17.20% | +1514.62% |
| Sep 18, 2026 | $7.16 | +1527.27% | $10.70 | +37.36% | +1489.91% |
| Sep 17, 2026 | $7.49 | +1602.27% | $9.82 | +26.06% | +1576.21% |
| Sep 16, 2026 | $7.81 | +1675.00% | $8.62 | +10.65% | +1664.35% |
| Sep 15, 2026 | $9.00 | +1945.45% | $8.44 | +8.34% | +1937.11% |
| Sep 14, 2026 | $11.63 | +2543.18% | $7.65 | -1.80% | +2544.98% |
| Sep 11, 2026 | $8.61 | +1856.82% | $5.24 | -32.73% | +1889.55% |
| Sep 10, 2026 | $6.18 | +1304.55% | $5.03 | -35.43% | +1339.98% |
| Sep 09, 2026 | $5.98 | +1259.09% | $6.38 | -18.10% | +1277.19% |
| Sep 08, 2026 | $- | $6.51 | -16.43% | - | |
| Sep 04, 2026 | $0.24 | -45.23% | $6.40 | -17.84% | -27.39% |
Page 1 of 5